Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Fate Therapeutics Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +7 vs. Q1 2025
- Shares held
- 79.7M
- −16.9M (−17.5%) vs. Q1 2025
- Total value
- $88.9M
- +$12.6M (+16.5%) vs. Q1 2025
- New holders
- 28
- 45 more added
- Sold out
- 21
- 40 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $193.2M |
| Q1 2026 | 158 | $88.9M |
| Q4 2025 | 146 | $70.9M |
| Q3 2025 | 143 | $101.6M |
| Q2 2025 | 139 | $88.9M |
| Q1 2025 | 132 | $76.3M |
| Q4 2024 | 159 | $166.5M |
| Q3 2024 | 164 | $401.6M |
| Q2 2024 | 182 | $401.1M |
| Q1 2024 | 167 | $904.0M |
| Q4 2023 | 159 | $357.2M |
| Q3 2023 | 171 | $202.9M |
| Q2 2023 | 188 | $519.6M |
| Q1 2023 | 182 | $641.6M |
| Q4 2022 | 228 | $1.07B |
| Q3 2022 | 239 | $2.41B |
| Q2 2022 | 233 | $2.70B |
| Q1 2022 | 249 | $3.92B |
| Q4 2021 | 250 | $5.66B |
| Q3 2021 | 266 | $5.67B |
| Q2 2021 | 272 | $8.20B |
| Q1 2021 | 260 | $7.73B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Assenagon Asset Management S.A. | 212,342 | $237.8K | 0.00% | −90,557−29.9% | Reduced |
| Renaissance Technologies LLC | 214,463 | $240.2K | 0.00% | +214,463 | New |
| Two Sigma Investments, LP | 228,405 | $255.8K | 0.00% | −13,467−5.6% | Reduced |
| Invesco Ltd. | 255,372 | $286.0K | 0.00% | +41,869+19.6% | Added |
| Gsa Capital Partners LLP | 256,722 | $288.0K | 0.02% | +256,722 | New |
| BNP Paribas Arbitrage, SA | 287,412 | $321.9K | 0.00% | −54,824−16.0% | Reduced |
| Susquehanna International Group, LLP | 289,232 | $323.9K | 0.00% | +111,872+63.1% | Added |
| Bank of New York Mellon Corp | 290,652 | $325.5K | 0.00% | −1,103−0.4% | Reduced |
| Nuveen, LLC | 336,872 | $377.3K | 0.00% | −42,216−11.1% | Reduced |
| Ameriprise Financial Inc | 339,714 | $380.5K | 0.00% | −71,618−17.4% | Reduced |
| Bruce & Co., Inc. | 429,188 | $480.7K | 0.16% | −120,812−22.0% | Reduced |
| XTX Topco Ltd | 432,328 | $484.2K | 0.02% | −26,980−5.9% | Reduced |
| Barclays PLC | 453,072 | $507.4K | 0.00% | +85,787+23.4% | Added |
| Jane Street Group, LLC | 465,820 | $521.7K | 0.00% | +402,129+631.4% | Added |
| Two Sigma Advisers, LP | 493,100 | $552.3K | 0.00% | −293,900−37.3% | Reduced |
| Monaco Asset Management SAM | 675,000 | $756.0K | 0.29% | −474,708−41.3% | Reduced |
| Woodline Partners LP | 712,650 | $798.2K | 0.00% | −711,517−50.0% | Reduced |
| Charles Schwab Investment Management Inc | 733,911 | $822.0K | 0.00% | +30,086+4.3% | Added |
| Northern Trust Corp | 844,350 | $945.7K | 0.00% | +49,377+6.2% | Added |
| AQR Capital Management LLC | 846,233 | $947.8K | 0.00% | +261,208+44.6% | Added |
| Millennium Management LLC | 879,688 | $985.3K | 0.00% | +564,811+179.4% | Added |
| Schonfeld Strategic Advisors LLC | 930,809 | $1.04M | 0.01% | −6,863,704−88.1% | Reduced |
| UBS Group AG | 962,672 | $1.08M | 0.00% | −588,409−37.9% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,213,736 | $1.36M | 0.01% | −989,587−44.9% | Reduced |
| Tang Capital Management LLC | 1,867,773 | $2.09M | 0.11% | 00.0% | Unchanged |
| Citigroup Inc | 1,903,738 | $2.13M | 0.00% | −33,395−1.7% | Reduced |
| State Street Corp | 2,229,121 | $2.50M | 0.00% | +119,056+5.6% | Added |
| Geode Capital Management, LLC | 2,429,167 | $2.72M | 0.00% | +159,558+7.0% | Added |
| Morgan Stanley | 2,433,575 | $2.73M | 0.00% | +193,517+8.6% | Added |
| Dimensional Fund Advisors LP | 2,437,729 | $2.73M | 0.00% | −153,829−5.9% | Reduced |
| Acadian Asset Management LLC | 2,459,954 | $2.75M | 0.01% | −13,611−0.6% | Reduced |
| Baker Bros. Advisors LP | 2,485,018 | $2.78M | 0.03% | −773,384−23.7% | Reduced |
| Goldman Sachs Group Inc | 2,511,676 | $2.81M | 0.00% | +52,702+2.1% | Added |
| Vestal Point Capital, LP | 2,515,000 | $2.82M | 0.15% | −8500.0% | Reduced |
| Johnson & Johnson | 3,379,064 | $3.51M | 1.05% | 00.0% | Unchanged |
| Citadel Advisors LLC | 4,543,867 | $5.09M | 0.00% | +254,708+5.9% | Added |
| Vanguard Group Inc | 8,766,764 | $9.82M | 0.00% | −1,543,689−15.0% | Reduced |
| BlackRock, Inc. | 10,810,481 | $12.1M | 0.00% | +128,702+1.2% | Added |
| Redmile Group, LLC | 12,872,946 | $14.4M | 1.53% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,680,580−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −433,192−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −397,177−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −131,830−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −118,186−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −82,024−100.0% | Sold out |
| Callan Family Office, LLC | 0 | $0 | 0.00% | −82,024−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −72,286−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −49,045−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −19,155−100.0% | Sold out |
| Wilshire Advisors LLC | 0 | $0 | 0.00% | −4,083−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −11,250−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −5,942−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −5,369−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −686−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −31−100.0% | Sold out |